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ApoptosisMitochondrial isoforms of creatine kinase (MtCK) and nucleoside diphosphate kinase (NDPK-D) are not
phylogenetically related but share functionally important properties. They both use mitochondrially
generated ATP with the ultimate goal of maintaining proper nucleotide pools, are located in the
intermembrane/cristae space, have symmetrical oligomeric structures, and show high afﬁnity binding to
anionic phospholipids, in particular cardiolipin. The structural basis and functional consequences of the
cardiolipin interaction have been studied and are discussed in detail in this review. They mainly result in a
functional interaction of MtCK and NDPK-D with inner membrane adenylate translocator, probably by
forming proteolipid complexes. These interactions allow for privileged exchange of metabolites (channeling)
that ultimately regulate mitochondrial respiration. Further functions of the MtCK/membrane interaction
include formation of cardiolipin membrane patches, stabilization of mitochondria and a role in apoptotic
signaling, as well as in case of both kinases, a role in facilitating lipid transfer between two membranes.
Finally, disturbed cardiolipin interactions of MtCK, NDPK-D and other proteins like cytochrome c and
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creatine kinase and nucleoside diphosphate kinase
The importance of cardiolipin (diphosphatidyl glycerol) for
mitochondrial topology and functioning has been mainly described
in the context of its association with carriers and the large protein
complexes of the inner mitochondrial membrane, where it seems
necessary for their proper function and/or the formation of super-
complexes [1–4]. The role of cardiolipin for the organization and
function of the neighboring intermembrane and cristae space has
attracted less attention. This compartment situated at the interface
between mitochondria and the cytosol is not only a site of intense
metabolite trafﬁc, but is also densely packed with proteins. For some
of these, cardiolipin serves as an anchor, including cytochrome c [5],
truncated Bid (t-Bid) [6], and also two metabolic kinases that are the
focus of this review: the mitochondrial isoforms of creatine kinase
(CK) and nucleoside diphosphate kinase (NDPK). Although both
kinases are phylogenetically very distinct, they share a number of
properties, which may have evolved as an adaptation to the speciﬁc
requirements of this compartment. Both occur as highly symmetrical
homo-oligomers, bind to cardiolipin and other anionic phospholipids,
are capable of bridging two membranes, and use mitochondrially
generated ATP with the ultimate goal to maintain proper nucleotide
pools.
A number of reviews are available on both kinase families and
their roles in cellular energy metabolism and nucleotide homeostasis
[7–17]. This article will rather focus on similarities and disparities
between the mitochondrial isoforms of CK and NDPK, which are
MtCK and NDPK-D. After a brief overview on isoforms, molecular
structure, catalytic mechanisms and membrane interaction, we will
focus on the complexes of the two kinases with cardiolipin and their
roles in cellular energetics and apoptosis.
1.1. Isoforms
1.1.1. Enzymatic and non-enzymatic activities and functions
Purine and pyrimidine nucleotides are fundamental for life, being
building blocks for the genetic material and many metabolic
reactions, but also providing an energy storage and distribution
system, mainly in the form of ATP and GTP. To fulﬁll these basic
requirements for life, several kinases have evolved to maintain
nucleotide pools at relatively stable levels, either globally in the cell,
or locally via association with speciﬁc cellular structures orcompartments. Among these kinases are CK and NDPK (also called
nm23 proteins), which transfer the γ-phosphate from mainly ATP
onto different substrates.
CK is part of the guanidino (or phosphagen) kinases family
[18,19]. These enzymes use Mg2+-complexed ATP to reversibly
phosphorylate guanidino substrates like creatine (Cr) to produce
large pools of ‘high-energy phosphate’ in the form of phospho-
creatine (PCr): ATP+Cr↔ADP+PCr. Elevated ATP generation
(temporally or locally, e.g. in mitochondrial intermembrane space)
drives the reaction towards PCr production, while ATP depletion (e.g.
in the cytosol) favors the reverse reaction to regenerate ATP. The
advantage of the CK/PCr system is that the CK substrates (Cr, PCr) are
more diffusible than ATP and metabolically inert, so they can
accumulate in the cell to high concentrations without affecting
regulatory feedback loops [20].
NDPKs are encoded by NME genes (also called NM23) and catalyze
the reversible exchange of the γ-phosphate between tri- and diphos-
phonucleosides, both beingMg2+-complexed: N1TP+N2DP↔N1DP+
N2TP. Thus the enzymes are non-speciﬁc in regard to the basemoiety of
donor and acceptor nucleotides. However, due to actual cellular
concentrations of the different nucleotides, the reaction in vivo mainly
proceeds in the direction of using ATP, e.g. formed by oxidative
phosphorylation, to generate the other triphosphonucleosides.
Additional non-enzymatic activities have been described for both
kinases, which may partially be due to complex formation with other
proteins, membranes or DNA, as outlined further below. Mainly NDPK
has a multifaceted role in differentiation, development, metastatic
dissemination or cilia functions, which could be linked to NDPK
function in transcription, DNAse activity and cilia ultrastructure
(reviewed in [15]). Concerning CK, this kinase has been more recently
involved in regulation of the actin cytoskeleton [21,22] and stabiliza-
tion of mitochondrial ultrastructure [23].
1.1.2. Evolution, cellular localization, and tissue distribution
Both kinases, CK and NDPK, occur as families of isoforms with
different subcellular localizations and tissue distribution. Existence
and speciﬁc properties of these isoenzymes are keys to the functions
of both kinases. While NDPKs are ubiquitous enzymes present
throughout all living cells, from bacteria to humans, guanidine kinases
like CK have evolved throughout the metazoan lineage and are mainly
found in cells and tissues with high and ﬂuctuating energy require-
ments [7]. CK isoforms are already widespread in lower chordates and
invertebrates, and are present in all vertebrates [18,19].
2034 U. Schlattner et al. / Biochimica et Biophysica Acta 1788 (2009) 2032–2047Four nuclear-encoded CK genes in vertebrates give rise to three
dimeric cytosolic isoforms (homodimeric muscle-type MM-CK and
brain-type BB-CK, heterodimeric MB-CK), and two mostly homo-
octameric mitochondrial isoforms (sarcomeric sMtCK, ubiquitous
uMtCK). Most tissues express combinations of two CK isoenzymes, a
cytosolic and a mitochondrial one. These are either MM-CK together
with sMtCK (in differentiated sarcomeric muscle, except heart muscle
expressingMM-,MB- and BB-CK alongwith sMtCK) or BB-CK together
with uMtCK (in most other tissues, except liver where CK is generally
very low or absent; for a recent review see [9]). The cytosolic CK
isoenzymes are not strictly soluble and can associate with cellular
structures like the sarcomeric M-band or membranes, in close
proximity to ATP-requiring processes. MtCK has a canonical targeting
sequence and is localized in the cristae, as well as in the
intermembrane space of mitochondria, in particular also at the
contact sites between inner and outer mitochondrial membranes.
Mitochondrial and cytosolic CK have diverged at least 670 million
years ago, suggesting that compartmentalized CK isoenzymes have
evolved very early during evolution [18] in the context of functional
coupling between MtCK and oxidative phosphorylation and metabo-
lite channeling as outlined below.
In humans (and probably all mammals) there are ten nuclear-
encoded genes (NME1 to 10) for the NDPK/Nm23 family [15].
Phylogenetically, these can be divided into two groups. The ﬁrst
group comprises NDPK-A to -D (or Nm23-H1 to H4, H stands for
human) showing high sequence homology and unambiguous NDPK
activity. The highly homologous NDPK-A and -B are very abundant,
mainly soluble cytosolic isoforms, thatmay however partially associate
with cellular structures. NDPK-C, a further cytosolic isoform, has a C-
terminal extension that may anchor it partially to cellular membranes.
NDPK-D is the only isoform possessing a speciﬁc signaling sequence,
targeting it tomitochondria. Allmembers of this group are ubiquitouslyFig. 1. Molecular structure and cardiolipin interaction of NDPK-D and sMtCK. (a) Molecular
chicken, PDB: 1crk) are shown in a schematic backbone representation of a side view with
dimeric building blocks of MtCK being similar. Perpendicular to this side view on top and bo
with anionic lipids, mainly cardiolipin, are numbered and given in a ball-and-stick repres
(NDPK-D) or four (sMtCK) binding motifs at each of the rotation symmetrical sides of the h
bound to cardiolipin bilayers, showing single molecules (left, scale bar: 50 nm) and a two-
arranged around a central channel and thus identiﬁes the rotational symmetric “top” or “bott
are a=b=145±4 Å and γ=90° [210].expressed in all organs, albeit at different levels. For example, NDPK-D
expression is highest in kidney, bladder, liver and prostate [24]. Gene
products of NME5 to 10 form a more divergent second group lacking
NDPK activity (except for the NME6 product) and mostly present in
ciliated structures such as primary cilia and sperm ﬂagella.
1.2. Structure–function relationships
1.2.1. Oligomer formation and molecular structures
Both, CK andNDPK, onlyexist as oligomers. The basic building block
of CKs is the dimer, which in the case ofMtCK reversibly associates into
octamers, depending on concentration, pH, ionic strength and
temperature, but octamers are the predominant form in vivo [25,26].
With NDPK, at least group 1 isoforms (NDPK-A to -D) form stable
homohexamers and additional heterohexamers (NDPK-A and -B).
High resolution X-ray structures are available for all CKs and most
group 1 isoforms of NDPK (Fig. 1a) [27–36].
Guanidino kinases like CK have acquired a speciﬁc fold linked to
their unique catalytic mechanism. Dimers are “banana-shaped”, with
the active sites of the monomers oriented towards the concave side. In
MtCK, dimers assemble into large symmetrical, cube-like octamers
with a central channel and overall dimensions of about
105×105×86 Å and 422 point group symmetry (Fig. 1a). The basis
of the dimer/dimer interface is a hydrophobic patch, which is
strengthened by a number of polar interactions. The latter vary
betweenMtCK isoenzymes,making the octamer of uMtCKmore stable
than that of sMtCK [26].
NDPK shows a typical αβ sandwich or ferredoxin fold. NDPK
hexamers are smaller than MtCK octamers and form a compact disk,
about 70 Å in diameter and 50 Å thick, showing dihedral D3 symmetry
(Fig.1a). The three dimers in the hexamer have strong, non dissociable
interactions among each other [36].models of hexameric NDPK-D (left, human, PDB: 1ehw) and octameric sMtCK (right,
a superimposed surface. Monomers are shown in different colors, with colors of the
ttom of the oligomers are the membrane binding interfaces. Basic residues interacting
entation. Note the symmetrical nature of the large homo-oligomers, presenting three
omo-oligomer. (b) Electron micrographs of negatively stained octameric human sMtCK
dimensional crystal (right). The latter clearly shows the four dimers (white moieties)
om” sides of the octamer as membrane binding faces. Unit cell parameters of 2D-crystals
2035U. Schlattner et al. / Biochimica et Biophysica Acta 1788 (2009) 2032–2047Although there is no homology in the sequence and the fold of
MtCK and NDPK-D, both mitochondrial kinases show similarities in
their quaternary structure (Fig. 1a). With their dimensions, both
oligomers just ﬁt in-between the two membranes forming the
peripheral mitochondrial intermembrane space (about 100 Å, [37]).
They are both highly symmetrical and expose two identical faces (top
and bottom in Fig. 1a), perpendicular to their four-fold or three-fold
axis. These faces have been identiﬁed as being attached to membranes
by directed mutagenesis and surface plasmon resonance (SPR) for
NDPK [38] and direct visualization of single molecules and 2D crystals
bound to cardiolipin layers [26,39] (Fig. 1b).
1.2.2. Enzyme catalysis
Both kinases have relatively high enzymatic activities [16,26]. Each
CKmonomer has its own catalytic center, buried in a cleft between the
N- and C-terminal domains. The catalytic mechanism of CK is of the
“random bi-bi” type, thus it needs association of both Mg2+-
complexed substrates. The kinase has acquired a speciﬁc fold to
achieve phosphoryl transfer and seems to lack essential catalytic
residues. Rather, substrates are already bound in a transition state-like
arrangement and the reaction is supported by large conformational
changes. A cross-talk between the two substrate binding sites in a
single active center as well as between two active centers in a dimer is
suggested by a pronounced substrate binding synergism (binding of
the ﬁrst substrate increases afﬁnity for the second [26]). This concept
has been also supported by some mutagenesis studies and analysis of
the occupancy of active sites in the CK transition state [40].
The reaction mechanism of NDPK is very different from CK. It is of
the “ping pong bi-bi” type, with only one substrate bound at a time
and the enzyme being transiently phosphorylated at an essential
histidine residue (for review [41]). No synergism between active sites
has been reported.
1.2.3. Membrane interaction
The mitochondrial isoforms of CK and NDPK differ from their
cytosolic counterparts by their canonical mitochondrial import pre-
sequence, a basic isoelectric point, and a high afﬁnity interaction with
anionic phospholipids, in particular cardiolipin. These properties
determine their exclusive (MtCK) or at least predominant (NDPK-D)
localization in the mitochondrial intermembrane and cristae space,
and their character as peripheral proteins of the inner mitochondrial
membrane [36,38,42,43]. With MtCK, only the octameric form binds
rapidly to anionic phospholipids, while the dimeric form binds more
slowly, possibly requiring prior octamerization at the membrane
surface [44].
Interaction of the kinases with cardiolipin is mainly determined by
electrostatic interactions [36,45] between the anionic phospholipids
and basic, surface-exposed motifs that have been mapped for both
kinases (Fig. 1a) [38,43]. In MtCK, the membrane binding domain is
located at the very C-terminal stretch of the monomers and comprises
three conserved basic residues (e.g. Lys369, Arg379, Lys380 in chicken
sMtCK) [43]. Interaction of NDPK-D with acidic phospholipids occurs
through a basic RRK motif (Arg89-Arg90-Lys91) which is unique to
the NDPK-D isoform of this enzyme [38]. It is situated on a surface-
exposed loop connecting α-helices αA and α2, which is in the most
divergent part of the NDPK sequences and is therefore suspected to
provide speciﬁcity for cellular functions.
These basic motifs of MtCK and NDPK-D are situated on ﬂexible,
relatively mobile segments that are poorly resolved in the electron
density maps of the X-ray structures and do not have deﬁned
secondary structures. Only substrate binding to NDPK-D can increase
stability of the ﬂexible RRK-loop [34]. These properties could provide
the necessary ﬂexibility for docking onto cardiolipin in a ﬂat
membrane [43].
In case ofMtCK, further interactions contribute to a tightmembrane
binding. These may include a surface-exposed loop carrying additionalbasic residues (Ala107–Gln115) [11], several clusters of Tyr with two
basic residues prone to interact with cardiolipin (see 2.1.1), and a
hydrophobic component. The latter is possibly due to a moderately
hydrophobic, proline-rich stretch of 6–7 amino acids at the C-terminus
[11]. This motif may physically interact with hydrophobic core of the
membrane, thus explaining effects seen on lipid packing and
membrane structure (see 2.1.1).
Due to the symmetry of the oligomeric structures, the octameric
MtCK and the hexameric NDPK-D expose three or four of these
bindingmotifs, respectively, at each top and bottom side (Fig. 1a). This
contributes to the high afﬁnity of the phospholipid interaction. The
two identical, opposite binding faces of these oligomers also allow the
bridging or crosslinking of twomembranes, while the dimeric form of
MtCK lacking these binding faces is unable to crosslink. Inter-
membrane contacts also occur in mitochondria, giving rise to so-
called contact sites between inner and outer membrane, and possibly
contributing to the narrow cristae invaginations (Fig. 2). Interaction
with the outer membrane may be somewhat weaker for both kinases,
since it contains only remnants of cardiolipin along with many other
anionic phospholipids. For example, a treatment suppressing contact
sites leads to a puriﬁcation of NDPK-D exclusively with inner
membrane. Details on the cardiolipin interaction of both kinases are
given in Section 2.1.1.
Finally, also using SPR with liposomes containing reconstituted
membrane proteins, a direct Ca2+-modulated high afﬁnity interaction
(KDb20 nM) between MtCK and the outer membrane VDAC (porin)
channel was detected [46]. This reinforces MtCK interaction with this
membrane.
1.3. Classical physiological functions
1.3.1. CK: temporal and spatial energy buffer
The CK/PCr system has an important physiological role in energy
homeostasis of sarcomeric muscles, brain and other organs with high
and ﬂuctuating energy requirements. Besides being a global cellular
energy buffer for maintaining ATP levels, CK isoforms occur in deﬁned,
subcellular microcompartments, either at sites of ATP generation
(glycolysis, mitochondrial oxidative phosphorylation) or at sites of
energy utilization (ATPases, ATP-gated ion channels, ATP-dependent
signaling events). At the sites of ATP generation, “high-energy
phosphoryls” are transferred from ATP to Cr, making up a large
cellular pool (up to 30 mM) of highly diffusible PCr, while at the sites
of ATP utilization PCr is locally used to regenerate ATP. These
microcompartments allow for a direct transfer of intermediates, ATP
and PCr, described by the concepts of functional coupling or
metabolite channeling [9,12]. Some of these microcompartments
have been characterized in greater detail, e.g. at the sarcomericM- and
I-band (with acto-myosin ATPase and glycolytic enzymes, respectively
[47,48]) and at the sarcoplasmic reticulum (with the calcium-pump
ATPase [49–51]). For M-band CK, the amino acids forming a “lysine
charge clamp” are known to facilitate the pH-dependent association
of the enzyme with distinct domains of myomesin and M-protein,
both constituents of a structural scaffold at the M-band [52,53].
Subcellularly compartmentalized cytosolic CK isoenzymes allow for
maintaining a high local ATP/ADP ratios in the vicinity of cellular
ATPases and a maximal change of the Gibbs free energy of ATP
hydrolysis.
Well deﬁned are also the mitochondrial microcompartments
involving proteolipid complexes containing among others MtCK,
VDAC and ANT, as well as phospholipids like cardiolipin (Fig. 3).
These MtCK microcompartments will be described in detail in
Section 2. Their multiple functions can be summarized as follows:
(i) PCr high-energy phosphoryl transfer and channeling from
mitochondria towards the cytosol, (ii) metabolic feedback regulation,
where cytosolic Cr is transphosphorylated in mitochondria by
matrix-generated ATP into PCr, and the resulting ADP is channeled
Fig. 2. Multiple cardiolipin-mediated localizations of NDPK-D and MtCK. NDPK-D (blue) and MtCK (green) occur at different locations within mitochondria, but always bound to
anionic phospholipids, mainly cardiolipin, at the innermitochondrial membrane. Further, at least MtCK can itself organize cardiolipin domains in this membrane (dark brown). These
cardiolipin interactions would favor co-localizationwith cardiolipin-bound adenine nucleotide translocator (ANT) in the innermembrane. (a) One fraction of both kinases is found in
the intermembrane space, whereMtCK and possibly also NDPK-D can induce so-called contact sites between outer and innermembrane. In addition, MtCK also directly interacts with
VDAC, thus setting up a channeling microcompartment (for details see Fig. 3). (b, c) Another fraction of both kinases is localized in the cristae space. They may contribute to the
formation of the tight invaginations towards the cristae space (cristae junctions) by crosslinking inner membrane (shown in (b) for MtCK), or being just attached at one side to the
membrane (c). Finally, (d) a fraction of NDPK-D is not accessible to substrates or antibodies in intact mitochondria or mitoplasts, respectively, andmay be located at thematrix side of
the inner membrane.
2036 U. Schlattner et al. / Biochimica et Biophysica Acta 1788 (2009) 2032–2047into the mitochondrial matrix to stimulate mitochondrial respiration
[54,55], (iii) delaying and preventing (together with Cr) mitochon-
drial permeability pore opening, an early event in apoptosis [56,57],
(iv) preventing the excessive free oxygen radical (ROS) formation, by
efﬁcient ADP recycling inside mitochondria and optimal coupling of
respiration with ATP synthesis [58], and ﬁnally (v) stabilizing
mitochondria by formation of contact sites between inner and
outer mitochondrial membranes [23]. Besides these well-documen-
ted functions of MtCK, new exciting ﬁndings indicate that octameric
MtCK, a highly symmetrical cube-like molecule that is able to
crosslink two membranes, is also involved in clustering cardiolipin
and lipid transfer between mitochondrial membranes [59,60].
1.3.2. NDPK: multifaceted roles in cell regulation and signaling
NDPKs control the overall intracellular nucleotide homeostasis,
equilibrating phosphorylation of the adenylate pools with the pools of
all other nucleotides. Several NDPK isoforms have been found
associated with different cellular compartments, such as cytosol,
nucleus, plasmamembrane andmitochondria and they are involved in
channeling of nucleotide between cellular compartments [61]. In
nucleotide biosynthesis, NDPK catalyzes the important step of NDP
phosphorylation into NTPs. However, due to their enzymatic activity
but possibly also to other properties like DNA binding and various
protein–protein interactions, they play a multifaceted role in ﬂagellar
motility [62,63], endocytosis [64,65], metastasis [66,67], cell adhesion
[68] and development [69]. Cytosolic NDPK interacts directly or
indirectly with small and heterotrimeric G-proteins, their exchange-
or regulatory factors [70,71].Mitochondrial NDPK was detected in the matrix and the extra-
matrix compartments and NDPK activity was shown associated with
contact sites [72,73]. NDPK-D is probably localized in both compart-
ments at least in overexpressing HeLa cells, but also NDPK-C and the
NME6 gene product have been reported to be partially associated with
mitochondria. Different functions have been proposed for mitochon-
drial NDPK. In the matrix, the enzyme can provide NTP for protein and
nucleic acid synthesis or can be associated to the Krebs cycle to
synthesize ATP from GTP provided by succinyl thiokinase [74]. A
matrix NDPKwas also proposed to be involved in short chain fatty acid
catabolism and to play a role in iron homeostasis by furnishing GTP
[75]. In the intermembrane/cristae space, NDPK was proposed to
synthesise cellular NTP using NDP, freely diffusible from cytoplasm
through the outer membrane, and ATP produced by oxidative
phosphorylation [76]. This reaction, similarly to MtCK reaction,
would play a role in feedback regulation of mitochondrial respiration,
by recycling of ADP to the mitochondrial matrix [38].
2. Role of cardiolipin for structure, function and localization of
kinases within mitochondria
2.1. Molecular interactions
2.1.1. Role of cardiolipin in mitochondrial kinase binding to membranes
Cardiolipin is a prominent phospholipid present mainly in the
inner mitochondrial membrane. This lipid interacts with a large
number of mitochondrial proteins. Cardiolipin molecules have been
resolved in the crystal structure of several mitochondrial
Fig. 3. Functions of theMtCKmicrocompartments inmetabolite channeling. In contact sites,MtCK simultaneously binds to the inner and outermembrane. Binding partner in the inner
membrane is cardiolipin, which allows a functional interactionwith adenine nucleotide translocator (ANT) that is situated in cardiolipinmembrane patches (dark brown). In the outer
membrane, MtCK interacts with other acidic phospholipids and, in a calcium-dependent manner, directly with mitochondrial VDAC. Black arrows indicate the preferred or exclusive
substrate and productﬂuxes. In this scheme, ATP generated by oxidative phosphorylation via the F0F1-ATPase is transported through the innermembrane byANT in exchange for ADP.
This ATP may either leave the mitochondrion directly via outer membrane VDAC or, preferentially, is accepted and transphosphorylated into PCr by octameric MtCK in the
intermembrane space. PCr then preferentially leaves the mitochondrion via VDAC and feeds into the large cytosolic PCr pool. ADP generated from the MtCK transphosphorylation
reaction is accepted by ANT and immediately transported back into the matrix to be rephosphorylated. In contact sites, this substrate channeling allows for a constant supply of
substrates and removal of products at the active sites ofMtCK. In cristae (not shownhere, see Fig. 2), only ATP/ADP exchange is facilitated through direct channeling to theMtCK active
site, while Cr and PCr have to diffuse along the cristae space to reach VDAC. The tight functional coupling of MtCK to the ANT leads to saturation of the ANT with ADP in the
intermembrane/cristae space, favoring ATP/ADP exchange and stimulating the F0F1-ATPase. The latter allows efﬁcient coupling of oxidation of redox equivalents to the reduction of
molecular oxygen by the respiratory chain, thus lowering the production of reactive oxygen species (ROS). On the other hand, the tight functional coupling of ANT to MtCK leads to a
saturation of MtCK with ANT-delivered ATP. Such a locally high ATP/ADP ratio in the vicinity of MtCK in combination with cytosolic Cr, entering the intermembrane space via VDAC,
drives the synthesis of PCr by MtCK with maximal thermodynamic efﬁciency. The high-energy phosphate compound PCr is then exported into the cytosol again via VDAC.
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plexes of the redox chain and transporters like adenylate translo-
case (ANT) involved in the exchange of metabolites across the
inner mitochondrial membrane. Cardiolipin is known to play
unique functional roles, in part through its speciﬁc interactions
with mitochondrial proteins. For example, cardiolipin stabilizes the
formation of supercomplex between proteins in the inner mito-
chondrial membrane [1,2]. In the case of ANT, cardiolipin is
required for transport activity [3] and for stabilizing complexes
between ANT and other proteins [4]. Furthermore, the extent of
activation by cardiolipin, even at a low mole fraction of 3%, varies
up to 30-fold, depending on the nature of the acyl chains of the
cardiolipin [3]. Cardiolipin also interacts with proteins binding
peripherally to the inner membrane, including cytochrome c and
kinases like MtCK and NDPK-D involved using ATP to generate PCr
or nucleoside triphosphates [38,42,43,77–79].
It has long been known that cardiolipin is important for the
binding of MtCK to the mitochondrial membrane [42,77–79]. This
binding is stabilized by electrostatic interactions between anionic
lipids and several C-terminal Lys residues of the protein [43]. In
addition, by analogy with cardiolipin that has been found in the
crystal structure of some proteins interacting with a cluster of a Tyr
residue plus two basic amino acid residues [80], these residues could
also represent a cardiolipin-binding motif for MtCK. In the known
crystal structures of octameric MtCK [27,29], such clusters of amino
acid residues exist in each of the four monomers forming the
membrane binding face of MtCK. There are thus two features at the
membrane binding interface of MtCK that can contribute to binding to
cardiolipin, i.e. a cationic cluster and a cluster of Tyr with two basic
residues.
NDPK-D has been characterized more recently as a peripheral
membrane protein binding electrostatically to anionic phospholipids
like cardiolipin [38]. Examination of the electrostatic surface potential
of the enzyme identiﬁed a cationic triad, in which the central Arg90 ispresent in NDPK-D but not in other NDPK isoforms. Mutation of Arg90
into an acidic residue mimicking the motifs found in cytosolic NDPK
isoforms yielded catalytically fully active and thus correctly folded
mutant enzyme [35], which however entirely lost its high afﬁnity
binding to cardiolipin [38]. Thus, switching a single basic residue into
an acidic amino acid resulting in three mutations per binding face in
the hexamer is sufﬁcient to prevent cardiolipin interaction. A basic
residue equivalent to R90 can be found in NDPK-D orthologue
sequences from mammals, ﬁsh and Xenopus, as well as, curiously, in
mitochondrial NDPK from Dictyostelium discoideum but not in the
mitochondrial NDPK of birds and of lower organisms such as
Drosophila, Caenorhabditis elegans and bacteria. Mitochondrial NDPK
from plants even has an acidic residue at the site equivalent to R90 like
mammalian cytosolic NDPKs. This suggests that speciﬁc mitochon-
drial membrane association appeared late in evolution and could be
important for vertebrate mitochondrial functions. Similarly, the MtCK
ability to interact structurally or functionally with mitochondrial
membranes or the ATP/ADP translocator (ANT) has been acquired at
the dawn of vertebrate evolution [18,43].
Membrane interaction of both kinases has been quantitatively
analyzed by site-directed mutagenesis and SPR spectroscopy with
artiﬁcial liposomes [26,38,43,79,81]. SPR allows a complete and
quantitative characterization of biospeciﬁc interactions including
rate constants and binding afﬁnities without labeling of interactant.
In this assay, biotinylated liposomes are immobilized on an avidin-
coated sensor chip and binding and dissociation kinetics of the
interacting protein are followed on-line. Binding was clearly depen-
dent on the presence of a minimal amount of anionic phospholipids
such as 16% phosphatidylserine, phosphatidylglycerol or cardiolipin.
About 16% cardiolipin would correspond to the fraction of this
phospholipid present in the inner mitochondrial membrane [82].
Phospholipids with neutral net charge like phosphatidylcholine or
phosphatidylethanolamine did barely interact with the kinases.
Increasing the salt concentration of the running buffer gradually
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binding drug doxorubicin [38], conﬁrming the electrostatic nature and
cardiolipin-speciﬁcity of the interaction. The afﬁnities determined for
cardiolipin are relatively high, with a KD of 17–53 nM for MtCK and
about 29 nM for NDPK-D. Afﬁnities for other anionic phospholipids
were lower.
Factors that contribute to these strong afﬁnities may be found in
the properties of the cationic binding motifs: (i) there are multiple (3
or 4) motifs per interaction site, (ii) binding motifs are situated on a
ﬂexible structure, ideal for docking, and (iii) they contain at least two
positive charges arranged in tandem and at a distance suitable to
interact with the doubly charged cardiolipin head group (e.g. 5–10 Å
between R89 and R90 in NDPK-D or K/R179 and K/H380 in MtCK,
depending on species and isoform).
Several characteristics of the MtCK/cardiolipin interaction could
be explained by a combination of electrostatic and hydrophobic
interactions. SPR spectroscopy identiﬁed a biphasic interaction with a
“fast” (e.g. uMtCK: kon=5.4±1.1·105 M−1 s−1) and a “slow” binding
site (e.g. uMtCK: kon=4.1±0.1·104 M−1 s−1), both having similar
afﬁnities [26,81]. Further, membrane-bound MtCK is resistant against
full detachment by high ionic strength buffers [83]. Different
methodological approaches have shown a disturbance of the lipid
bilayer upon MtCK binding [43–45,84] and vice versa some subtle
structural changes in the β-sheet structures of MtCK occur upon lipid
binding [84]. Finally, a preliminary thermodynamic analysis of the
interaction also supports a participation of electrostatic and hydro-
phobic components (Schlattner, unpublished data). Thus, the
mechanism of MtCK membrane interaction may resemble another
cardiolipin-binding protein, cytochrome c [85,86]. A model consistentFig. 4. Mechanistic model for membrane binding of MtCK. The model is based on (i) a
biphasic binding behavior ofMtCK octamers (green) to anionic phospholipids, indicating
a fast and a slow binding site (analysis by surface plasmon resonance spectroscopy), (ii)
structural effects of MtCK binding on the lipid bilayer as observed by independent
methods, and (iii) the temperature-dependence of binding, indicating the participation
of electrostatic and hydrophobic interactions (Schlattner et al., unpublished data). The
model shows membrane binding of one out of the four monomers at eachMtCK binding
face. Electrostatic attraction between C-terminal patches of basic residues (Lys, Arg, or
His, depending on the MtCK isoform) and acidic cardiolipin (dark brown) leads to fast
binding at themembrane surface. In parallel, a slower association ofMtCK is suggested to
involve a hydrophobic interaction, possibly an insertion of a C-terminal hydrophobic
stretch (yellow) into the lipid bilayer. This could anchor MtCK more ﬁrmly in the
membrane, making it also more difﬁcult to detach from membranes and thus also
explaining the slow dissociation rate observed for this binding site.with these data is shown in Fig. 4. While fast binding could occur via
the basic residues at the MtCK C-terminus and would be purely
electrostatic, slow binding could involve subtle structural changes in
MtCK to further expose the hydrophobic stretch at the C-terminus and
to partially penetrate into the lipid bilayer.
2.1.2. Bridging membranes and stabilizing mitochondria
Mitochondria are organelles composed of two membranes. The
outer membrane separates the mitochondria from the cytoplasm,
while the inner membrane folds into cristae within the mitochondria.
The morphology of mitochondria is dynamic with the organelle
capable of undergoing fusion and ﬁssion as well as internal
remodeling of the cristae. One of the factors stabilizing mitochondrial
structure (e.g. cristae junctions and the intermembrane space, in
particular the so-called contact sites) may be the presence of the
oligomeric mitochondrial kinases. The crystal structures of these
proteins show that they have identical ﬂat surfaces on opposite sides
of the oligomer (Fig. 1a) that give them a shape suitable for binding to
a ﬂat bilayer membrane and for bridging two membranes (Fig. 2a).
In model systems it has been shown that MtCK can promote an
increase in the size of liposomes and that this property is dependent on
the protein being in its octameric state [79]. It was further demon-
strated that this association is due to aggregation of liposomes and
does not involve membrane fusion or leakage [59]. The inner
mitochondrial membrane contains about 16% cardiolipin that would
provide a site for binding of these proteins. These proteins could
crosslink two segments of the innermembranewithin cristae (Fig. 2b).
However, there is also evidence that both isoforms of MtCK bridge the
inner and outer membrane at mitochondrial contact sites where these
two membranes become juxtaposed (Fig. 2a) [72].
Contact sites are domains within the mitochondrial membrane [87],
which are regulateddynamic structures [88]. Such connections between
the outer and peripheral inner membranes of mitochondria that have
been observed by morphological analysis, e.g., in chemically ﬁxed
mitochondria where the intermembrane space is enlarged [89], as
jumps in the fracture planes of freeze-fracturedmitochondria [90], or in
three-dimensional electron tomography [91]. How to reconcile the
symmetrical NDPK-D and MtCK structure with an asymmetrical lipid
distribution between the two mitochondrial membranes? Cardiolipin
may sequester to the sites where these proteins bind to the outer
membrane [92], providing sufﬁcient cardiolipin to facilitate interaction
with these proteins. However, both kinases also show binding to other
anionic phospholipids that are common in the outer membrane and
these may also contribute. In addition, there is also evidence that MtCK
interacts with VDAC in the outer membrane through a process
modulated by calcium [46]. Furthermore, voltage gating at contact
sites is modulated by the presence of cardiolipin [93,94]. Mitochondrial
lipids therefore play important and speciﬁc biological roles [95].
Additional evidence obtained with intact mitochondria indicates
that uMtCK induces the formation of contact sites between inner and
outer mitochondrial membranes and maintains mitochondrial integ-
rity [23]. Liver mitochondria, largely devoid of MtCK, were compared
to those from transgenic mice expressing uMtCK in their livers.
Transgenic mitochondria showed an increased number of contact sites
as revealed by electron microscopy, and an improved resistance
against lysis by detergent or oxidative agent. In contrast, silencing
uMtCK expression by siRNA destabilized mitochondrial ultrastructure
(see 2.2.4) [96].
Given the NDPK-D structure, it is tempting to speculate that this
oligomer can also crosslink inner and outer mitochondrial mem-
branes. NDPK-D has been shown to promote crosslinking of liposomes
[38,59]. This phenomenon does not occur with the R90D mutant or
with liposomes devoid of anionic lipids [38]. NDPK-D of the
intermembrane space may also be present in contact sites, since it
distributes between outer and inner membranes when isolated from
mitochondria without prior destruction of such contact sites [36].
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As mentioned above, contact sites in mitochondria are enriched in
both MtCK [23] as well as cardiolipin [92]. There is evidence that the
formation of a domain enriched in these two components occurs
spontaneously. Differential scanning calorimetry (DSC) was used to
assess the changes in the miscibility of lipid components of the
membrane. The application of DSC for studying the formation of
membrane domains induced by peptides or proteins has recently been
discussed [97]. DSC has the advantage of not requiring bulky labels
that can modify the behavior of the system. This application of DSC is
based on the fact that a pure lipid component will give rise to a
sharper phase transition with a higher enthalpy than will the same
lipid component present in a mixture. This is analogous to a pure
crystal exhibiting a sharpmelting behavior over a narrow temperature
range compared with an impure substancemelting over a broad range
of temperatures. By these criteria we have shown that uMtCK will
bind to cardiolipin and sequester that lipid away from the rest of the
membrane, resulting in the remaining lipid having a sharper phase
transition of higher enthalpy at a temperature closer to that of the
pure zwitterionic component [60]. This phenomenon occurs only with
the octameric form of MtCK and not with the dimer nor after thermal
denaturation of the protein. The phase segregation is not observed
when cardiolipin is replaced with another anionic lipid, phosphatidyl-
glycerol, indicating a degree of speciﬁcity in the binding of this protein
to phospholipids. It is possible that NDPK-D could also favor
cardiolipin clustering. This deserves to be further studied.
2.1.4. Lipid transfer
The close approach of the inner and outer mitochondrial
membranes at contact sites provides a location where the transfer of
lipids between the two membranes becomes more probable. Such
lipid transfer is known to occur in intact mitochondria, e.g. during
apoptosis, in the form of cardiolipin transfer from the inner to the
outer mitochondrial membrane [98–101]. Cardiolipin and its precise
mitochondrial localization plays an important role in apoptosis [102]
that will be discussed below (Section 3).
Phospholipid transfer between membranes has been shown to be
facilitated by uMtCK and by NDPK-D. Using a lipid composition
resembling that of mitochondrial contact sites [92] it was shown that
each of these two proteins can bridge vesicles and allow their close
approach. This marked kinase protein-dependent increase in the rate
of phospholipid transfer between liposomes occurs without concomi-
tant fusion of the vesicles. The transfer process is speciﬁc for the
oligomeric state of the protein that can bridge membranes and does
not occur with the dimeric form of uMtCK [59]. There is some
speciﬁcity in the lipid transfer carried out by uMtCK in that pyrene-PC
is not transferred. This is in accord with the fact that this enzyme does
not bind to PC alone [81]. uMtCK and NDPK-D are not homologous in
amino acid sequence, nor in the details of their structure, yet they have
related oligomeric structures, forming two opposing ﬂat surfaces and
both proteins facilitate the transfer of lipid. As compared to the
oligomeric kinases,monomeric cytochrome c also binds to cardiolipin-
rich membranes and in certain conditions is enriched in contact sites
[103], but it cannot bridge twomembranes and thus does not promote
lipid transfer [59].
Lipid transfer must also occur in intact mitochondria since it is
known that cardiolipin is synthesized on the mitochondrial inner
membrane [82] but there is also cardiolipin detectable in the outer
mitochondrial membrane which must have been transferred from the
inner membrane. One pathway for such transfer would be at ANT-
containing contact sites where cardiolipin is enriched [92] and where
part of uMtCK and a mitochondrial NDPK are located [36,72]. The
binding of MtCK to the membrane induces changes/modiﬁcations in
the interfacial properties as measured by the ﬂuorescent probe
Laurdan [84] in a manner consistent with the protein causing
dehydration of the membrane surface. Membrane dehydration isoften accompanied by rigidiﬁcation of the membrane [104] as well as
destabilization of the bilayer because of increased intrinsic negative
curvature. It is possible that binding of thesemitochondrial proteins to
cardiolipin-rich membranes induces loss of interfacial water and
allows facilitated lipid transfer if there are two juxtaposed bilayers.
Such a mechanism would be very different from that of lipid transfer
proteins that have a speciﬁc lipid binding site and carry the lipids
directly between membranes. The octameric structure of MtCK
presents on internal hole. However, the diameter of this cavity is not
wide enough to allow for passage of cardiolipin. The mechanism of
lipid transfer by MtCK is currently under investigation.
Finally, there is potential for a regulation of the lipid transfer rate
between mitochondrial membranes by these kinases. The dimeric
form of uMtCK is not active in lipid transfer and cannot bridge two
membranes. Thus, any change in the octamer/dimer ratiowould affect
lipid transfer. With NDPK-D, the hexameric structure is stable, but the
level of expression varies considerably among different cell types and
may provide another mechanism of regulation.
Since uMtCK and NDPK-D are normally present at contact sites in
mitochondria, why doesn't the concentration of cardiolipin on inner
and outer mitochondrial membranes become equal? With intact
mitochondria one also has to consider the net ﬂux of cardiolipin,
which is a result of the balance of several processes. There is a
mechanism for the rapid inward movement of lipids in mitochondria
[105], and a mitochondrial lipid scramblase, PLS3 (see below), also
known to promote the redistribution of lipids between mitochondrial
membranes [106]. Thus, there are multiple pathways for the move-
ment of lipid between mitochondrial membranes and the relative
importance of each of these will depend on the expression level of the
relevant proteins, as well as on the regulation of their lipid transfer
activity, e.g. by factors like mitochondrial calcium. It is interesting in
this context that the substrate of MtCK, Cr, signiﬁcantly protects the
mitochondrial permeability transition pore against opening, a trigger
of apoptosis induction (see [56]). The novel, rather striking function of
MtCK (ubiquitous and sarcomeric) and NDPK-D, in being capable of
mediating lipid transfer between two membranes has been demon-
strated in vitro [59].
The interbilayer movement of lipid in mitochondria likely has
several functional consequences. Elucidation of the contribution of
mitochondrial kinases in this process in vivo and its detailed
mechanism will be a challenge for future experiments.
2.2. Mitochondrial microcompartments
2.2.1. Speciﬁc localization of intermembrane proteins: contact sites,
cristae junctions
There are two locations in mitochondria where the oligomeric
kinases are located. These are the intermembrane space (IMS, Fig. 2a)
and the cristae space (Fig. 2c) [13,38,107]. In the IMS, proteins can
bridge the inner and outer mitochondrial membranes. This bridging is
important for the direct use of ATPmade by oxidative phosphorylation
and product release across the outer membrane into the cytoplasm. It
also is likely the site for the transfer of cardiolipin from the inner to the
outer membrane in apoptosis. In the cristae space, the oligomeric
kinases are still coupled to oxidatively generated ATP, but reaction
products have to diffuse through the cristae junctions to leave the
mitochondria. These cristae junctions, if tightly sealed, can act as a
barrier to free diffusion of proteins and metabolites [108]. Based on
their strong crosslinking properties, the oligomeric kinases may be
involved (Fig. 2b). This suggestion is in accord with the observation
that cristae remodeling is required for the full release of cytochrome
c during apoptosis [109]. Finally, a fraction of NDPK-D has been
located in the matrix space (Fig. 2d). Interestingly, liver which is the
only organ lacking MtCK, is particularly rich in NDPK-D. This may
indicate that MtCK and NDPK-D could be redundant for certain
functions.
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Another functional property common to MtCK and NDPK-D is the
ability to stimulate respiration through local synthesis of ADP in the
intermembrane/cristae space and close so-called functional coupling
to respiration via ANT.
The process is well described for MtCK as Cr-stimulated respiration
and was shown to involve formation of proteolipid complexes
containing MtCK and ANT (Fig. 3) [91,107,110,111]. A large body of
evidence supports a speciﬁc metabolic function of proteolipid
complexes containing MtCK and ANT [9,12,20,112–114]. In peripheral
contact sites, co-localization of MtCK with ANT, direct interaction of
MtCK with VDAC, and possibly also the diffusion limitations at the
outer mitochondrial membrane [115] create amicrocompartment that
maintains a privileged exchange of substrates and products, called
metabolite channeling or functional coupling (Fig. 3) [54,56,114,116].
Here, MtCK preferentially uses mitochondrial ATP that is exported via
ANT to phosphorylate Cr. Vice versa, the locally produced ADP is
immediately re-imported into the mitochondrial matrix space via
ANT, an obligatory ATP/ADP antiporter, and PCr is then released into
the cytosol via VDAC. However, the degree of such metabolite
channeling seems to vary among different tissues, species, and
developmental states [117,118]. Experimental evidence for direct
functional coupling between MtCK and oxidative phosphorylation
has come from in vivo 31P-MRI (magnetic resonance imaging) studies
showing PCr resynthesis coupled to respiration [119], as well as from
respirometry measurements with skinned muscle ﬁbers from wild-
type and transgenic mice lacking MtCK [55], and PCr generation in
isolated respiring mitochondria kept without external nucleotides
[56]. The latter study indicates an internal mitochondrial pool of
adenine nucleotides that is constantly recycled via MtCK complexes
with only minor leakage into the cytosol. Metabolite channeling
withinMtCK complexes would circumvent the low diffusibility of ADP
and diffusion restrictions that may exist at the mitochondrial outer
membrane, both relevant at the given low intracellular free ADP
concentration [120]. Furthermore, mitochondrial metabolism would
not be regulated by intracellular free ADP concentration per se, but
rather by intra-mitochondrial ADP production triggered via cytosolic
Cr [55,112,114]. In cristae, MtCK associates with ANT alone, which
would still allow metabolite channeling between these two proteins.
Cr and PCr, however, have to diffuse along the cristae space through
the cristae junctions to reach VDAC. If the cristae junctions indeed
would limit diffusion for ADP [108], this would add to the limited
permeability of the outer mitochondrial membrane and could
reinforce the dynamic compartmentation of a mitochondrial pool of
adenylates. Proteolipid complexes containing MtCK and ANT also
exhibit a direct protective effect on the mitochondrial permeability
transition pore (PTP). This reversible and cyclosporin-sensitive pore in
the inner mitochondrial membrane is triggered by multiple signals,
including Ca2+ and reactive oxygen species [121,122]. PTP opening
leads to dissipation of the membrane potential, mitochondrial
swelling and permeabilization of the outer membrane. The latter
may trigger apoptosis by the release of proapoptotic proteins like
cytochrome c or lead to necrotic cell death due to energy depletion
[121,123,124]. Time course, degree and abundance of PTP openingmay
be decisive in determining whether a given cell undergoes apoptotic
or the necrotic cell death. In vitro and in vivo, contact site complexes
containing ANT and VDAC exhibit some properties of PTP [125–127],
although they are not the (only) pore-forming constituents and may
have rather regulatory functions [122,128]. The efﬁcient ADP recycling
byMtCK insidemitochondria and optimal coupling of respirationwith
ATP synthesis has been shown to prevent excessive formation of
reactive oxygen species (ROS) in brain mitochondria [58].
Also NDPK is able to locally regenerate ADP from ATP through its
NTP synthesis activity, and to stimulate oxidative phosphorylation.
Coupling of the NDPK reaction to oxidative phoshorylation was ﬁrst
shown in rat liver mitochondria [76,129]. Recently, it has been shownin HeLa cells that are naturally almost devoid of NDPK-D, that stable
expression of NDPK-D efﬁciently stimulates respiration in the
presence of the speciﬁc NDPK substrate TDP [38]. However, the
stimulatory effect has been less important in HeLa cells transfected
with a binding-deﬁcient NDPK-D mutant, which is catalytically
equally active. This indicates that for tight functional coupling of
NDPK-D to oxidative phosphorylation, local ADP regeneration in the
mitochondrial intermembrane space per se is not sufﬁcient, but NDPK-
D has to be in the membrane/cardiolipin-bound state. Thus, in the
intermembrane space, NDPK-D is proposed to couple ATP export
through ANT to the synthesis of the other nucleoside triphosphates
[76], e.g. GTP. In support of this hypothesis, it has been observed that
in plants there is a close interaction between the mitochondrial NDPK
and ANT, as indicated by the co-immunoprecipitation of the two
proteins [130].
Mitochondria are compartmentalized organelles with a dynamic
structure, which can change (fusion and ﬁssion) with the cellular
bioenergetic state, the cell cycle and with apoptosis under the control
of GTPases bound to the inner and outer mitochondrial membranes
[131]. Local regeneration of GTP by NDPK-D bound to the inner
membrane could thus be involved in these processes. It should be
noted that cristae remodeling is a vertebrate feature [132] and thus it
evolved together with the membrane association of NDPK-D. Further
functional consequences of coupling of NDPK reaction to oxidative
phosphorylation remain to be elucidated.
2.2.3. Putative role of membrane clustering for the formation of
microcompartments
MtCK binds with high afﬁnity to membranes containing cardio-
lipin (2.2.1). MtCK also causes the rearrangement of membrane lipids
and facilitates the clustering of cardiolipin (2.1.3). The clustering of
cardiolipin will provide a site on the membrane to which MtCK will
bind with higher afﬁnity. The enrichment of these proteins together
with cardiolipin at speciﬁc locations in the mitochondria will stabilize
the membrane junctions of contact sites and possibly also cristae
junctions. Neither these proteins attracting cardiolipin to these sites
nor the cardiolipin forming a cluster to which the proteins can bind
occur as separate events, but rather the two aspects are mutually
interdependent. As a consequence, the systemwill rearrange to lower
the total energy and this will result in the formation of micro-
compartments as described above.
2.2.4. Knock-in and knock-out models of MtCK
Transgenic mice have given some insight into the speciﬁc role of
MtCK in the organization of energy metabolism. A gain of function
model was engineered by expressing CK isoenzymes in the mouse
liver naturally devoid of these enzymes. Mitochondria of uMtCK
expressing liver, in the presence of CK substrates, were clearly
protected from Ca2+-induced opening of the mitochondrial perme-
ability transition, part of the mitochondrial apoptotic signaling path-
way [57]. However, as soon as the MtCK octamer was dissociated into
dimers by the components of the transition state analogue complex
(ADP, Cr, NO3−, Mg2+) [25], the protective effect on Ca2+-induced MPT
pore opening was diminished [57,127]. Thus, octameric MtCK may
delay PTP by supplyingADP into thematrix space, known to inhibit PTP,
or by directly interfering with VDAC and ANT, putative constituents or
regulators of the pore. These mitochondria were also more resistant to
detergent lysis and anthracycline-induced damage [23].
Transgenic animals with single or combined CK gene deletions
representing loss of function models were viable ([133,134], for a
review see [135]). They showed a mild phenotype, depending on the
deleted CK isoenzyme(s), mostly because numerous structural,
biochemical and metabolic adaptations were compensating for the
loss of the CK/PCr system. In particular the combined MM-CK/sMtCK
deﬁciency, in addition to such adaptations, also revealed a signiﬁcantly
worsened phenotypewhen analyzed under strenuous conditions [133].
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sequestration and pH regulation [136], since cytosolic MM-CK is
functionally coupled to the Ca2+ pump of the sarcoplasmic reticulum
[51] and maintains cellular pH [20]. Experiments with permeabilized
cardiacmuscleﬁbers ofMM-CK/sMtCK-deﬁcientmice have added new
evidence on the regulation ofmitochondrial respiration by ADP [55]. Cr
plus ATP increased respiration rate much more than ATP alone, even
when an exogenous ADP-trap system was added to maintain a low
extramitochondrial ADP. However, this stimulatory effect of Cr
disappeared in sMtCK-deﬁcient, but not in MM-CK-deﬁcient, muscle
ﬁbers. This indicated that it is the ADP produced by MtCK in the
intermembrane space of mitochondria that is responsible for stimula-
tion of mitochondrial respiration. In brain, lack of uMtCK affects
neurological functions such as spatial learning acquisition and synaptic
signaling in the acoustic signal response [137]. No transgenic model is
yet available for NDPK-D.
In contrast to these constitutive genetic mouse models, a recent
approach has used an inducible siRNAmodel for silencingof BB-CK and
uMtCK isoenzymes in different cell lines [96]. This model of acute CK
downregulation should eliminatemost compensatory adaptations and
thus facilitate the discovery of the phenotype directly linked to a lack of
CK. Indeed, the observed phenotype was clearly different from those
observed in the various CK knockout mice. Inhibition of MtCK had the
most striking effects, slowing down cell proliferation, reducing cellular
glycogen, increasing necrosis, and drastically changing mitochondrial
ultrastructure, while BB-CK silencing had weak or no effects on these
parameters [96]. The normally elongated mitochondria were changed
into spherical organelles that had lost most of their cristae. The
morphology of the remaining cristae was changed, showing an
enlarged cristae space. Together with a reduced membrane potential
observed in these cells, these data reveal a considerable loss of function
of the mitochondrial compartment as a consequence of uMtCK
inhibition. This ﬁnding corroborates the functional and structural
roles of cardiolipin-bound MtCK as outlined above.
3. Relationships to apoptosis
3.1. Cytochrome c binding to cardiolipin
An important step in themitochondrial pathway of apoptosis is the
release of cytochrome c, as well as other proteins, from the
mitochondria to the cytosol where it can initiate the formation of
apoptosomes and activation of caspases [138–140]. Cytochrome c is
part of the electron transport pathway inmitochondria and it is bound
to cardiolipin on the inner membrane [5,141–143]. The strength of the
binding of cytochrome c to mitochondria is also dependent on the
molecular nature of cardiolipin. Cardiolipin species containing
saturated acyl chains bind cytochrome c more weakly than species
with polyunsaturated acyl chains [144]. In order to pass from the
mitochondria to the cytosol, cytochrome cmust ﬁrst be released from
binding to cardiolipin before crossing the permeabilized outer
membrane. The various factors that control the movement of this
protein into the cytosol, in particular in the context of MtCK and NDPK
functions, are reviewed below.
3.2. Changes in mitochondrial morphology
3.2.1. Cytochrome c release by opening cristae junctions or permeability
transition — putative roles of mitochondrial kinases
About 80% ofmitochondrial cytochrome c are normally sequestered
within cristae folds, but rapidly released towards the mitochondrial
periphery and in the cytosol via permeabilization of the outer
mitochondrial membrane during apoptosis [124]. It is known that
apoptosis is accompanied by morphological rearrangements of
mitochondria and that full release of cytochrome c during apoptosis
requires cristae remodeling [109] or a mitochondrial PTP depending onremodeling of cristae junctions [145]. In fact, cristae junctions may
prevent free diffusion of cytochrome c. Since both MtCK and NDPK-D
are capable of crosslinking adjacent membranes, they may have a role
in stabilizing such cristae junctions (Fig. 2b).
Yet another role of MtCK in apoptosis is linked to its presence in
contact sites (Fig. 2a). At these sites it is suggested that uMtCK directly
interacts with cardiolipin on the inner mitochondrial membrane,
stabilizing a cardiolipin-rich domain and VDAC in the outer membrane
to bridge the inner membrane and the outer membrane (2.2). ANT is
also abundant in contact sites [146], and known to tightly bind to
cardiolipin [147] and to be functionally dependent on this lipid [3].
Proteolipid complexes containing MtCK, VDAC and ANT have been
isolated [103,148]. These have also been suggested to represent
structural or regulatory components of the PTP, the apoptosis-inducing
pore, which is structurally still elusive [122,128]. Functionally, this pore
has been involved in energy ﬂux processes, mitochondrial Ca2+-
handling, and apoptosis [7,56,146,149], while sustained opening of PTP
rather triggers necrosis [150]. In transgenic mice, the presence of MtCK
has been shown to reduce PTP opening [56]. Further, since the function
of contact sites is modulated by the presence of cardiolipin [3,93,94],
any change in cardiolipin content and distribution at contact sites may
also affect PTP and apoptosis.
3.2.2. Putative role of GTP/NDPK-D in OPA1 dependent morphological
change
OPA1 is a mitochondrial dynamin-like GTPase that is important for
the fusion of mitochondrial membranes [151], and more generally in
maintaining mitochondrial cristae structure [152,153] and cristae
remodeling [154]. Loss of OPA1 results in more rapid release of
cytochrome c [153,155]. OPA1, like MtCK and NDPK-D, is bound to the
inner membrane facing the IMS. Co-localization of NDPK-D with OPA1
could modulate OPA1 functions such as cytochrome c release through
cristae junctions, both by stabilizing these junctions through the
bridging of membranes, as with MtCK (Fig. 2b), as well as through its
catalytic activity that locally provides GTP.
3.3. Oxidation
Oxidative stress and the generation of reactive oxygen species
(ROS) in mitochondria are known to trigger apoptosis [156,157].
Cardiolipin and proteins that interact with cardiolipin have an
important role in this process.
3.3.1. Oxidation of MtCK
MtCK, like all CK isoenzymes, is extremely susceptible to damage
by reactive oxygen and nitrogen species and a prime target of these
species in mitochondria [7]. Oxidative modiﬁcation of speciﬁc
cysteines and tryptophans of MtCK leads to enzymatic inactivation,
as well as reduced octamer formation andmembrane binding capacity
[158,159]. In vivo it has been shown during ischemia-reperfusion in
heart that the octameric form ofMtCK that bridges the inner and outer
mitochondrial membranes is destabilized by oxidation, resulting in
the dissociation of the protein into dimers [160] that can no longer
interact with cardiolipin. Such oxidation of MtCK contributes to
impairment of energy homeostasis and facilitates the opening of the
membrane permeability transition pore, which leads to apoptosis
[110]. The cardiac sarcomeric isoform of MtCK is much more
susceptible to oxidation than is the ubiquitous form [158].
3.3.2. Cardiolipin oxidation and cytochrome c release
It has been demonstrated that the generation of reactive oxygen
species (ROS) results in the release of cytochrome c from membrane-
bound forms, together with a loss of cardiolipin and of cytochrome c
oxidase activity [161]. Added cardiolipin was able to almost
completely restore the ROS-induced loss of cytochrome c oxidase
activity. However, no restoration was obtained with peroxidized
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correlation between cardiolipin oxidation, its loss from mitochondria
and the release of cytochrome c from the mitochondria into the
cytoplasm [162]. It has been directly shown that the oxidation of
cardiolipin prevents the binding of cytochrome c [163] and that this
lipid oxidation is required in order for cytochrome c to be released
from mitochondrial membranes [164]. Oxidation of cardiolipin is
promoted by apoptosis [165] and enzymes that destroy ROS inhibit
apoptosis [166,167]. These results demonstrate the important role of
cardiolipin oxidation in the release of cytochrome c.
Cytochrome c in complex with cardiolipin can itself catalyze
peroxidation of cardiolipin [168], promoting cytochrome c release
into the cytosol to trigger apoptosis. Some mechanistic details of this
process have been elucidated. The interaction of cytochrome c with
cardiolipin results in a loosening of the tertiary structure of the protein
[169–171]. The peroxidase activity of cytochrome c, which is low for
cytochrome c in solution [172], increases by two order of magnitude
upon cardiolipin binding [168,173,174]. This is due to a shift of the
redox potential of cytochrome c by 350 to 400 mV [175]. The authors
suggest the existence of two pools of mitochondrial cytochrome c.
One is involved in electron transport, reduced by Complex III and
effectively scavenging superoxide anions, while the other is bound to
cardiolipin and acts as a lipid peroxidase to oxidize cardiolipin,
resulting in the release of cytochrome c from the mitochondria [175].
There are additional mechanisms for the oxidation of cardiolipin
by mitochondrial peroxidases [176]. It has recently been demon-
strated that Bax-induced apoptosis requires not only the generation of
ROS, but also the expression of a cardiolipin-speciﬁc peroxidase [177].
Furthermore, it should be pointed out that Bax does more than induce
oxidation of cardiolipin and the release of cytochrome c into the
cytosol, since other mitochondrial proteins such as Smac/Diablo, that
trigger the activation of cytosolic caspases, are also released from the
mitochondria as a result of cardiolipin oxidation. It has been suggested
that the oxidized cardiolipin may also be involved in the permeabi-
lization of mitochondria [168].
Finally, it is known that the VDAC channel of the outer mitochon-
drial membrane is an important regulator of mitochondrial function
and apoptosis [178]. Mitochondrial lipids, including cardiolipin,
regulate the conductance of this channel [93]. Thus it is conceivable
that oxidation of cardiolipin also affects the properties of VDAC and
facilitates the progression of apoptosis.
3.4. t-Bid binding to cardiolipin
The caspase-cleavage product of the proapoptotic Bcl-2 protein
Bid, i.e. t-Bid, has a high afﬁnity for cardiolipin [179–181]. t-Bid almost
completely eliminates the peroxidase activity of cytochrome c bound
to cardiolipin [182]. It is possible that t-Bid competes with cytochrome
c for cardiolipin, resulting in the release of cytochrome c from the
membrane and the cessation of cardiolipin oxidation.
It is also known that there is a signiﬁcant amount of hydrolysis of
cardiolipin during apoptosis to produce monolysocardiolipin and
dilysocardiolipin that accumulate in the cell [6,183]. t-Bid also binds to
monolysocardiolipin [183], however the binding afﬁnity of t-Bid for
the lyso-forms of cardiolipin is ﬁve-fold lower than for the intact
cardiolipin [182]. This would rather reduce the competition with
cytochrome c for binding to cardiolipin and thereby maintain
cardiolipin oxidation.
3.5. Effects of anthracyclines on cardiolipin/MtCK interaction
Anthracyclines with the leading drug doxorubicin, are widely used
as cancer chemotherapeutic agents. However, their use is limited by a
signiﬁcant risk of cardiotoxicity. Molecular mechanisms and tissue-
speciﬁcity of this toxicity are unclear. They involve binding to
cardiolipin, which may be more deleterious in a mitochondria-richoxidative tissue like heart [184]. Thus, these drugs may interfere with
any cardiolipin-related mitochondrial process such as the multiple
functions of the cardiolipin-bound kinases MtCK and NDPK-D. Indeed,
doxorubicin treatment in patients leads to a decrease in “high-energy”
phosphates (NTP, PCr). Interference of the drugs with the essential
properties of MtCK was characterized in detail in vitro with
recombinant enzyme, in isolated mitochondria and in perfused
heart [159,184,185]. Anthracyclines immediately inhibited membrane
binding ofMtCK, probably because of competitive binding of the drugs
to cardiolipin. Other deleterious effects on MtCK like octamer
dissociation, enzymatic inactivation and formation of high molecular
mass crosslinking products were much slower. These long term
deleterious effects were caused by oxidative damage, mainly affecting
the highly susceptible MtCK cysteines [159]. Deleterious effects were
signiﬁcantly more pronounced for sMtCK than for uMtCK, suggesting
molecular damage of the cardiac sMtCK isoform as a factor in
anthracycline cardiotoxicity.
Studies with intact mitochondria conﬁrmed that the drug caused a
rapid detachment of MtCK frommembranes over a period of less than
one hour, followed by oxidative damage [185]. The loss of MtCK/
membrane binding and resulting disturbance of functional coupling
betweenMtCK and ANTmight contribute to the observed inhibition of
Cr-stimulated respiration, in addition to impairment of components of
the respiratory chain. Again, heart mitochondria expressing sMtCK
were particularly sensitive to these effects. The resulting cardio-
toxicity of these drugs is then likely caused by a competition between
the anthracycline and MtCK for binding to cardiolipin. Since NDPK-D
also binds to the inner membrane through cardiolipin, it could also be
detached by doxorubicin treatment and play a role in drug toxicity.
This would deserve further studies.
3.6. Cardiolipin transfer between membranes
3.6.1. Roles of mitochondrial kinases
As has been discussed above (2.1.4), both MtCK and NDPK-D
promote the transfer of lipids between model membranes. This
property has important implications for apoptosis since it is known
that cardiolipin is transferred from the inner to the outermitochondrial
membrane during apoptosis and that this lipid provides a recognition
site for Bcl-2 proteins to bind to mitochondria and promote apoptosis.
Exposure of cardiolipin-rich domains at contact sites in mitochondria
facilitate the binding of the proapoptotic proteins t-Bid and Bax
[156,179,181,186–188]. Monolysocardiolipin is present in mitochondria
as an intermediate in the remodeling of the acyl chain composition of
cardiolipin [189]. Like cardiolipin, lysocardiolipin also binds to t-Bid and
its concentration in the mitochondria increases during FAS-induced
apoptosis [183] as well as in Barth syndrome [190,191]. Cardiolipin is
synthesized on the mitochondrial inner membrane [82,192] and the
major fraction of cardiolipin is present on the inner leaﬂet of the inner
membrane [193]. Early in apoptosis, cardiolipin moves to the
mitochondrial surface [98–100]. This process requires ﬂip-ﬂop across
the inner membrane, interbilayer transfer from inner membrane to
outer membrane, as well as ﬂip-ﬂop across the outer membrane. We
have recently shown that MtCK and NDPK-D facilitate the transfer of
lipids between these membranes [59]. Transfer of lipids between
bilayers is more commonly facilitated by speciﬁc lipid transfer proteins
[194–196]. However, there is a report indicating that t-Bid also has lipid
transfer activity [197], but thismay be a result of its structural similarity
to other lipid transfer proteins [198]. Thus, the observation that uMtCK
and NDPK-D have such lipid transfer activity is novel. The biological
importance of this lipid transfer is suggested by the fact that a
promyelocytic leukemia cell line that exhibits less exposed cardiolipin is
resistant to apoptosis [98]. Furthermore, a lipid transfer protein from
maize produces proapoptotic effects on mammalian mitochondria
[101]. In addition, tumor cells that are poorly differentiated have fewer
contact sites [199], and such cells are also more resistant to apoptosis
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presence of contact sites. NDPK-D and MtCK also differ in their
expression levels in different cancer cell lines. This may have
consequences for the susceptibility of these cells to chemotherapeutic
agents, since a major drawback of such therapies is the resistance of
tumor cells to apoptosis. However the relationship of apoptosis toMtCK
expression may be biphasic, since in addition to the proapoptotic
transfer and exposure of cardiolipin on the cell surface promoting
apoptosis, there is also anantiapoptotic role ofMtCK. It keeps thematrix
ADP concentration high and prevents ROS formation by maintaining
electron transport for ADP rephosphorylation (Fig. 3). High ADP and
lowROSare bothantiapoptotic, preventingPTPand avoiding cardiolipin
oxidation that would result in cytochrome c release.
3.6.2. Role of PLS3 scramblase protein
In order to become exposed on the surface of mitochondria,
cardiolipin not only has to move between the inner and outer
membranes, but it also has to undergo transbilayer diffusion from one
monolayer to the other (ﬂip-ﬂop) in the outer membrane. We
demonstrated that the proapoptotic Bcl-2 protein, Bax, promotes
lipid ﬂip-ﬂop [201].
In addition to lipid transfer promoted by the oligomeric mitochon-
dria kinases, several other mitochondrial proteins are involved in lipid
translocation including the phospholipid scramblase, PLS3 [106,202],
and an unidentiﬁed ﬂipase that promotes transfer of phospholipids
into the mitochondria [105]. Phospholipid scramblases (PLS) are
enzymes that play a key role in lipid movement in cells, inducing
bidirectional movement of lipid across the bilayer [203]. PLS3 is an
isoform that is targeted to mitochondria [106]. Overexpression of a
mutant PLS3(F258V), which abolishes the conserved calcium-binding
motif [204], suppressed mitochondrial respiration and resulted in a
unique mitochondrial morphology with densely packed cristae [106].
The outer membrane has increased cardiolipin after UV-irradiation
and overexpression of PLS3 [106]. We have shown that phospholipid
ﬂip-ﬂop in liposomes containing reconstituted PLS3 is accelerated by
both t-Bid and calcium and is inhibited by Bcl-2 [205]. Increased
expression of PLS3 decreases the rate of reacylation of lysocardiolipin,
but increases the rate of cardiolipin biosynthesis, suggesting that the
rate of cardiolipin synthesis is sensitive to the location of cardiolipin in
themitochondria that in turn is affected by PLS3 [206]. It has also been
shown that tumor necrosis factor-related apoptosis-inducing ligand
(TRAIL) activates PLS3 and causes changes in the distribution of
cardiolipin in the cell leading to apoptosis [205,207].
PLS3 is also phosphorylated by protein kinase C delta (PKCδ) [202].
This isoform of PKC is targeted to the mitochondria and is activated in
apoptosis [208]. PLS3 is phosphorylated by PKCδ at Thr21 and is the
mitochondrial target of PKCδ-induced apoptosis [209]. Cells with
overexpression of PLS3, but not the phosphoinhibitory mutant PLS3
(T21A), are more susceptible to apoptosis induced by AD198, an
extranuclear targeted anthracycline that activates PKCδ. The phos-
phomimetic mutant of PLS3(T21D) by itself can induce apoptosis in
HeLa cells. Using proteoliposomes with addition of pyrene-labeled
phosphatidylcholine (PC) at the outer leaﬂet, we measured the lipid
ﬂip-ﬂop activity of PLS3 and its phosphorylation mutant. The mutant
PLS3(T21D) is more potent than wild-type PLS3 or PLS3(T21A) to
transfer pyrene-PC from the outer leaﬂet to the inner leaﬂet of
liposomes. Based on our previous ﬁnding that PLS3 enhances t-Bid-
induced mitochondrial damage, we tested the hypothesis that PLS3
enhances cardiolipin translocation to the mitochondrial surface and
facilitates t-Bid targeting. Fluorescein-labeled t-Bid(G94E) was used
as a probe to quantify cardiolipin on the surface of mitochondria.
Mitochondria from cells treated with AD198 or cells expressing PLS3
(T21D) had a higher level of t-Bid-binding capacity than control cells
or cells expressing wild-type PLS3. These ﬁndings indicate that
phosphorylation of PLS3 by PKCδ induces PLS3 activation to facilitate
mitochondrial targeting of t-Bid and apoptosis [209].4. Outlook
Recent studies have revealed striking similarities between NDPK-D
and the well characterized MtCK isoforms. They suggest that both
kinases, localized in the same cellular compartment, have evolved to
fulﬁll similar functions. Two such functions, the functional coupling to
inner membrane ANT and mitochondrial respiration via strong
cardiolipin interaction and the intermembrane lipid transfer have
already been demonstrated for both kinases. Further studies have to
show, whether the multiple roles of MtCK in mitochondrial structure
and apoptotic signaling, related to ROS production, protein or
cardiolipin oxidation, and PTP formation, also apply for NDPK-D.
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